NASDAQ:TNGX | Profit Breakdown | Tango Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$59.79M-$55.34M-$55.34M
2026-03-31$0.00-$48.77M-$45.51M-$45.51M
2025-12-31$0.00-$41.86M-$38.8M-$38.75M
2025-09-30$53.81M$14.07M$15.87M$15.88M
2025-06-30$3.18M-$40.97M-$38.82M-$38.85M
2025-03-31$5.39M-$42.53M-$39.84M-$39.88M
2024-12-31$4.12M-$40.91M-$37.62M-$37.67M
2024-09-30$11.61M-$32.88M-$29.11M-$29.17M
2024-06-30$19.88M-$29.55M-$25.49M-$25.55M
2024-03-31$6.47M-$42.26M-$37.87M-$37.91M
2023-12-31$5.43M-$35.01M-$30.72M-$30.76M
2023-09-30$10.73M-$25.63M-$22.24M-$22.26M
2023-06-30$14.6M-$23.25M-$20.65M-$20.71M
2023-03-31$5.77M-$30.29M-$28.01M-$28.01M
2022-12-31$6.41M-$30.57M-$29.01M-$29.06M
2022-09-30$6.92M-$29.92M-$29.05M-$29.05M
2022-06-30$5.77M-$25.2M-$24.86M-$24.86M
2022-03-31$5.76M-$25.38M-$25.21M-$25.21M
2021-12-31$5.72M-$21.98M-$21.87M-$22.05M
2021-09-30$6.79M-$19.57M-$19.53M-$19.59M
2021-06-30$18.15M-$4.56M-$4.51M-$4.49M
2021-03-31$6.39M-$12.08M-$12.03M-$12.11M
2020-12-31$9.14M-$8.94M-$8.86M-$8.86M
2020-09-30-$11.26M-$26.76M-$26.8M-$26.8M
2020-06-30-$8.39M
2020-03-31-$7.91M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$62.38M-$111.29M-$101.59M-$101.59M
2024-12-31$42.07M-$145.6M-$130.09M-$130.3M
2023-12-31$36.53M-$114.17M-$101.61M-$101.74M
2022-12-31$24.86M-$111.07M-$108.12M-$108.18M
2021-12-31$37.04M-$58.19M-$57.94M-$58.24M
2020-12-31$7.66M-$52.2M-$51.97M-$51.97M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.